Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With Dyslipidemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Patients who assigned to the pitavastatin treatment first group will be given the pitavastatin 4 mg qd treatment for 12 weeks after randomization, followed by wash‐out period of 3 weeks and life‐style modification treatment for 12 weeks. Similarly, patients who assigned to the life‐style modification treatment first group, will be treated with life‐style modification treatment for 12 weeks after randomization, followed by wash‐out period of 3 weeks and pitavastatin treatment for 12 weeks.
Epistemonikos ID: 248e6241bd6ab8e7154a75d6bee55ed69338672e
First added on: May 21, 2024